0001209191-22-034546.txt : 20220606
0001209191-22-034546.hdr.sgml : 20220606
20220606164554
ACCESSION NUMBER: 0001209191-22-034546
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220603
FILED AS OF DATE: 20220606
DATE AS OF CHANGE: 20220606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERSHBERG ROBERT
CENTRAL INDEX KEY: 0001274139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 22998622
MAIL ADDRESS:
STREET 1: 3005 FIRST AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 651311552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-03
0
0001434316
FATE THERAPEUTICS INC
FATE
0001274139
HERSHBERG ROBERT
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO
CA
92131
1
0
0
0
Common Stock
2022-06-03
4
S
0
672
22.75
D
2009
D
Required number of shares sold by the reporting person to cover tax obligations in connection with the vesting of 2,681 shares of Common Stock underlying RSUs granted to the reporting person on June 2, 2021. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Represents the weighted average sale price of the shares sold from $22.53 to $22.86 per share. The Reporting Person will provide, upon request
by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price
within the ranges set forth in footnote 2.
/s/ Cindy Tahl, as Attorney-in-Fact
2022-06-06